4.0
Feb 24, 2015
Recommend
CEO approval
Business Outlook
Pros
There was good alignment from discovery to clinical research, also good internal collaborations. Most staff like working with each other and that helps team work.
Cons
Therapeutic areas no longer include oncology unfortunately and many of the very experienced senior scientists already left the company due to restructuring or pursuit of other opportunities.